NCT03443492 2025-12-30
Pancreas
National Health Research Institutes, Taiwan
Phase 2 Completed
Clinical Trials
62 trialsNCT03013010 2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3 Completed
NCT06048913 2025-07-04
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT03406299 2025-05-22
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
National Health Research Institutes, Taiwan
Phase 2 Completed
NCT04195828 2025-04-01
Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
Fujian Medical University
Phase 2 Completed
NCT03878472 2024-12-16
Neoadjuvant Immunotherapy for Resectable Gastric Cancer
Qilu Hospital of Shandong University
Phase 2 Completed
NCT04207918 2024-05-16
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT04694183 2024-02-07
The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer
The First Hospital of Jilin University
Phase 2 Completed
NCT03607656 2023-12-18
CHANGE
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Completed
NCT03267121 2023-10-17
A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Completed
NCT03726021 2023-03-29
Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer
Qingdao Central Hospital
Phase 2 Completed
NCT03769935 2023-03-29
Maintenance Therapy for Small-cell Lung Cancer
Qingdao Central Hospital
Phase 2 Completed
NCT03660449 2022-10-26
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT03162510 2022-04-07
SOLAR
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT02131493 2022-03-02
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
Zhejiang University
Phase 2 Completed
NCT03051373 2021-08-09
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract
Chinese PLA General Hospital
Phase 2 Completed
NCT02564367 2021-04-29
S-1 adjuvant
AIO-Studien-gGmbH
Phase 1/2 Completed
NCT02128243 2021-03-26
MATEO
AIO-Studien-gGmbH
Phase 2 Completed
NCT03668366 2021-02-11
S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Fudan University
Phase 2 Completed
NCT04338438 2020-11-10
Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer
Beijing Friendship Hospital
Phase 2 Completed
NCT02459652 2020-10-27
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Japan Adjuvant Study Group of Pancreatic Cancer
Phase 2 Completed
NCT02114359 2020-10-23
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Phase 3 Completed
NCT02704143 2020-10-19
Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer
Changhai Hospital
Phase NA Completed
NCT02813967 2020-09-16
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Zhejiang Cancer Hospital
Phase 3 Completed
NCT02606916 2020-09-04
Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
Sun Yat-sen University
Phase 2 Completed
NCT01516944 2020-02-13
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Hebei Medical University
Phase 2/3 Completed
NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT03129256 2019-12-10
EASE
Changzhou Cancer Hospital of Soochow University
Phase 2 Completed
NCT02592538 2019-11-19
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Completed
NCT02347904 2019-11-18
SOX
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1 Completed
NCT02387138 2019-08-22
SIRINOX
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1 Completed
NCT01831531 2019-02-15
Study of S-1 in Combination With Radiotherapy in Esophageal Cancer
Fudan University
Phase 2 Completed
NCT01824459 2019-01-23
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sun Yat-sen University
Phase 3 Completed
NCT01783951 2018-07-19
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Capital Medical University
Phase 1/2 Completed
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT01963325 2018-02-05
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
Sun Yat-sen University
Phase 2 Completed
NCT01781520 2018-01-18
Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer
Capital Medical University
Phase 1/2 Completed
NCT01430052 2017-11-21
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases
Phase 2 Completed
NCT01693419 2017-08-23
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Hallym University Medical Center
Phase 2 Completed
NCT02527785 2017-08-23
Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer
Hallym University Medical Center
Phase 2 Completed
NCT02229058 2017-07-27
Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer
Sun Yat-sen University
Phase 2 Completed
NCT01364376 2016-08-23
Focus
Zhejiang University
Phase NA Completed
NCT00660894 2016-08-03
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT01693445 2016-02-19
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Hallym University Medical Center
Phase 1 Completed
NCT01671449 2015-11-30
SOPP
Asan Medical Center
Phase 3 Completed
NCT01128998 2015-10-19
Sorafenib Plus S-1 in Advanced Solid Tumors
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT00438100 2015-05-29
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Japan Breast Cancer Research Network
Phase 2 Completed
NCT01110941 2015-05-19
SCI-101
Peking University
Phase 1/2 Completed
NCT01459185 2014-09-25
A Feasibility Study of Oral Adjuvant Chemotherapy With S-1
Nagasaki University
Phase 2 Completed
NCT02146703 2014-05-26
Gemcitabine and S-1 for Advanced Biliary Tract Cancer
Hallym University Medical Center
Phase 2 Completed